Literature DB >> 12461683

European-wide opposition against the breast cancer gene patents.

Gert Matthijs1, Dicky Halley.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12461683     DOI: 10.1038/sj.ejhg.5200924

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  7 in total

1.  Open biotechnology: licenses needed.

Authors:  Yann Joly
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  Patenting genes.

Authors:  Gert Matthijs
Journal:  BMJ       Date:  2004-12-11

3.  Impact of gene patents on diagnostic testing: a new patent landscaping method applied to spinocerebellar ataxia.

Authors:  Nele Berthels; Gert Matthijs; Geertrui Van Overwalle
Journal:  Eur J Hum Genet       Date:  2011-08-03       Impact factor: 4.246

4.  Gene and genetic diagnostic method patent claims: a comparison under current European and US patent law.

Authors:  Isabelle Huys; Geertrui Van Overwalle; Gert Matthijs
Journal:  Eur J Hum Genet       Date:  2011-06-08       Impact factor: 4.246

Review 5.  The European opposition against the BRCA gene patents.

Authors:  Gert Matthijs
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

6.  Myriad Genetics: In the eye of the policy storm.

Authors:  E Richard Gold; Julia Carbone
Journal:  Genet Med       Date:  2010-04       Impact factor: 8.822

Review 7.  Models for facilitating access to patents on genetic inventions.

Authors:  Geertrui Van Overwalle; Esther van Zimmeren; Birgit Verbeure; Gert Matthijs
Journal:  Nat Rev Genet       Date:  2006-02       Impact factor: 53.242

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.